THRX
Theseus Pharmaceuticals, Inc.
$5.01M
Cluster buy
Discretionary Insider Activity
Date:
07/17/2023
Insiders:
ORBIMED ADVISORS LLC, director, and 2 others
Prior trend:
27 weeks of no discretionary insider activity

Summary

A $5.01M cluster buy for Theseus Pharmaceuticals, Inc. (THRX) on 07/17/2023 after 27 weeks of no discretionary insider activity.

Reports

Action Amount Date Insider Role(s) SEC Filing No
Buy $1.46M 07/19/2023 ORBIMED ADVISORS LLC + 3 Director, a 10%+ owner 0000947871-23-000760
Buy $1.46M 07/19/2023 GORDON CARL L Director, a 10%+ owner 0000947871-23-000761
Buy $2.08M 07/19/2023 Foresite Capital Management V, LLC + 3 A 10%+ owner 0001209191-23-042720

Transactions

Action Amount Date Insider Security Type SEC Code
Buy $1.00M 07/17/2023 ORBIMED ADVISORS LLC Common Stock Discretionary Purchase
Buy $462K 07/17/2023 ORBIMED ADVISORS LLC Common Stock Discretionary Purchase
Buy $1.00M 07/17/2023 GORDON CARL L Common Stock Discretionary Purchase
Buy $462K 07/17/2023 GORDON CARL L Common Stock Discretionary Purchase
Buy $1.55M 07/17/2023 Foresite Capital Management V, LLC Common Stock Discretionary Purchase
Buy $524K 07/17/2023 Foresite Capital Management V, LLC Common Stock Discretionary Purchase

Metadata

Signal ID:
DHHIQH7hMzORvTCX
Detected on:
07/16/2023